Page last updated: 2024-10-25

desipramine and Cirrhosis, Liver

desipramine has been researched along with Cirrhosis, Liver in 2 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, HY1
Witt, CJ1
Jbeily, N1
Hurtado-Oliveros, J1
Giszas, B1
Lupp, A1
Gräler, MH1
Bruns, T1
Stallmach, A1
Gonnert, FA1
Claus, RA1
Reidenberg, MM1
Affrime, M1

Other Studies

2 other studies available for desipramine and Cirrhosis, Liver

ArticleYear
Acid Sphingomyelinase Inhibition Prevents Development of Sepsis Sequelae in the Murine Liver.
    Scientific reports, 2017, 09-27, Volume: 7, Issue:1

    Topics: Animals; Apoptosis; Cell Line; Desipramine; Disease Models, Animal; Drug Evaluation, Preclinical; Fe

2017
Influence of disease on binding of drugs to plasma proteins.
    Annals of the New York Academy of Sciences, 1973, Nov-26, Volume: 226

    Topics: Arrhythmias, Cardiac; Arteriosclerosis; Blood Proteins; Blood Urea Nitrogen; Carbon Radioisotopes; C

1973